|
Sign In to gain access to subscriptions and/or personal tools.
|
Effect of Propionylcarnitine on Changes in Endothelial Function and Plasma Levels of Adhesion Molecules Induced by Acute Exercise in Patients with Intermittent Claudication
Antonio Silvestro, MD
Departments of Clinical Medicine and Cardiovascular and Immunological Sciences, University of Naples "Federico II," Naples, Italy, antoniosilvestro{at}libero.it
Vittorio Schiano, MD
Departments of Clinical Medicine and Cardiovascular and Immunological Sciences, University of Naples "Federico II," Naples, Italy
Roxana Bucur, MD
Departments of Clinical Medicine and Cardiovascular and Immunological Sciences, University of Naples "Federico II," Naples, Italy
Gregorio Brevetti, MD
Departments of Clinical Medicine and Cardiovascular and Immunological Sciences, University of Naples "Federico II," Naples, Italy
Francesco Scopacasa, PhD
Laboratory Medicine, University of Naples "Federico II," Naples, Italy
Massimo Chiariello, MD
Departments of Clinical Medicine and Cardiovascular and Immunological Sciences, University of Naples "Federico II," Naples, Italy
In patients with intermittent claudication, treadmill exercise may cause acute deterioration of endothelial function and increase in plasma concentrations of adhesion molecules. The authors evaluated the efficacy of intravenously administered propionylcarnitine (PLC) in preventing these phenomena. Thirty-six claudicants with postexercise decrease in brachial artery flow-mediated dilation (FMD) were randomized to either placebo or PLC (600 mg as a single bolus followed by 1 mg/kg/min for 60 minutes). In the 18 patients randomized to placebo, FMD markedly decreased with exercise before (from 6.8 ±0.4% to 4.0 ±0.4%; p<0.001) and after treatment (from 6.5 ±0.4% to 4.4 ±0.5%; p<0.001). By contrast, in the PLC group, FMD significantly decreased with exercise before treatment (from 8.0 ±0.7% to 4.4 ±0.4%; p<0.001), but not after active drug administration (from 7.1 ±0.7% to 6.0 ±0.6%; p=0.067). The difference between treatments was not significant (p=0.099; ANOVA). However, in the PLC group, the authors found that the greater the exercise-induced deterioration in endothelial function before treatment, the greater the capacity of PLC to prevent a postexercise decrease in FMD (r = -0.50, p=0.034). Accordingly, they analyzed data in the 19 patients with a baseline exercise-induced decrease in FMD 45% (ie, the median FMD reduction in the entire group of 36 patients), and found that the exercise-induced FMD decrease was less after PLC than after placebo (p=0.046, ANOVA). In the same subgroup, the exercise-induced increase in plasma concentrations of soluble vascular cell adhesion molecule-1 (sVCAM-1) was significantly higher before than after treatment in patients randomized to PLC (23.4 ±5% vs 15.3 ±7%, p=0.007). In conclusion, in patients with intermittent claudication suffering from a greater endothelial derangement after treadmill, PLC administration provided a protective effect against deterioration of FMD and increase of sVCAM-1 induced by exercise
References
- Ross R: Atherosclerosisan inflammatory disease. N Engl J Med 340:115-126, 1999.[Free Full Text]
- Bogaty P, Hackett D, Davies G, et al: Vasoreactivity of the culprit lesion in unstable angina. Circulation 90:5-11, 1994.[Abstract/Free Full Text]
- Quyyumi AA: Endothelial function in health and disease: New insights into the genesis of cardiovascular disease. Am J Med 105:32S-39S, 1998.[Medline]
[Order article via Infotrieve]
- Brevetti G, Silvestro A, Di Giacomo S, et al: Endothelial dysfunction in peripheral arterial disease is related to increase in plasma markers of inflammation and severity of peripheral circulatory impairment but not to classic risk factors and atherosclerotic burden. J Vasc Surg 38:374-379, 2003.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Corretti MC, Anderson TJ, Benjamin EJ, et al: Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: A report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 39:257-265, 2002.[Abstract/Free Full Text]
- Brevetti G, Martone VD, de Cristofaro T, et al: High levels of adhesion molecules are associated with impaired endothelium-dependent vasodilation in patients with peripheral arterial disease. Thromb Haemost 85:63-66, 2001.[Web of Science][Medline]
[Order article via Infotrieve]
- Blankenberg S, Barbaux S, Tiret L: Adhesion molecules and atherosclerosis. Atherosclerosis 170:191-203, 2003.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Silvestro A, Scopacasa F, Oliva G, et al: Vitamin C prevents endothelial dysfunction induced by acute exercise in patients with intermittent claudication. Atherosclerosis 165:277-283, 2002.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Brevetti G, De Caterina M, Martone VD, et al: Exercise increases soluble adhesion molecules ICAM-1 and VCAM-1 in patients with intermittent claudication. Clin Hemorheol Microcirc 24:193-199, 2001.[Web of Science][Medline]
[Order article via Infotrieve]
- Belch JJ, Mackay IR, Hill A, et al: Oxidative stress is present in atherosclerotic peripheral arterial disease and further increased by diabetes mellitus. Int Angiol 14:385-388, 1995.[Web of Science][Medline]
[Order article via Infotrieve]
- Brevetti G, Chiariello M, Ferulano G, et al: Increases in walking distance in patients with peripheral vascular disease treated with L-carnitine: A double-blind, cross-over study. Circulation 77:767-773, 1988.[Abstract/Free Full Text]
- Brevetti G, Perna S, Sabba C, et al: Superiority of L-propionylcarnitine vs L-carnitine in improving walking capacity in patients with peripheral vascular disease: An acute, intravenous, double-blind, cross-over study. Eur Heart J 13:251-255, 1992.[Abstract/Free Full Text]
- Brevetti G, Perna S, Sabba C, et al: Propionyl-L-carnitine in intermittent claudication: Double-blind, placebo-controlled, dose titration, multicenter study. J Am Coll Cardiol 26:1411-1416, 1995.[Abstract]
- Brevetti G, Diehm C, Lambert D: European multicenter study on propionyl-L-carnitine in intermittent claudication. J Am Coll Cardiol 34:1618-1624, 1999.[Abstract/Free Full Text]
- Hiatt WR, Regensteiner JG, Creager MA, et al: Propionyl-L-carnitine improves exercise performance and functional status in patients with claudication. Am J Med 110:616-622, 2001.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Cerretelli P, Marconi C: L-carnitine supplementation in humans. The effects on physical performance. Int J Sports Med 11:1-14, 1990.[Medline]
[Order article via Infotrieve]
- Reznick AZ, Kagan VE, Ramsey R, et al: Antiradical effects in L-propionyl carnitine protection of the heart against ischemia-reperfusion injury: The possible role of iron chelation. Arch Biochem Biophys 296:394-401, 1992.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Packer L, Valenza M, Serbinova E, et al: Free radical scavenging is involved in the protective effect of L-propionyl-carnitine against ischemia-reperfusion injury of the heart. Arch Biochem Biophys 288:533-537, 1991.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Stroh R, Christopher TA, Lopez BL, et al: L-propionyl carnitine, an endogenous ester in fatty acid metabolism, exerts anti-shock and endothelial protective effects in rat splanchnic ischemia-reperfusion injury. Shock 9:216-222, 1998.[Web of Science][Medline]
[Order article via Infotrieve]
- Hickey NC, Shearman CP, Gosling P, et al: Assessment of intermittent claudication by quantitation of exercise-induced microalbuminuria. Eur J Vasc Surg 4:603-606, 1990.[CrossRef][Medline]
[Order article via Infotrieve]
- Iwata H, Matsushita M, Nishikimi N, et al: Intestinal permeability is increased in patients with intermittent claudication. J Vasc Surg 31:1003-1007, 2000.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Kirk G, Hickman P, McLaren M, et al: Interleukin-8 (IL-8) may contribute to the activation of neutrophils in patients with peripheral arterial occlusive disease (PAOD). Eur J Vasc Endovasc Surg 18:434-438, 1999.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Edwards AT, Blann AD, Suarez-Mendez VJ, et al: Systemic responses in patients with intermittent claudication after treadmill exercise. Br J Surg 81:1738-1741, 1994.[Web of Science][Medline]
[Order article via Infotrieve]
- Verma S, Wang CH, Li SH, et al: A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulation 106:913-919, 2002.[Abstract/Free Full Text]
- Murohara T, Kugiyama K, Ohgushi M, et al: Cigarette smoke extract contracts isolated porcine coronary arteries by superoxide anion-mediated degradation of EDRF. Am J Physiol 266(3 Pt 2):H874-H880, 1994.[Web of Science][Medline]
[Order article via Infotrieve]
- Arsenian MA: Carnitine and its derivatives in cardiovascular disease. Prog Cardiovasc Dis 40:265-286, 1997.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Triggiani M, Oriente A, Golino P, et al: Inhibition of platelet-activating factor synthesis in human neutrophils and platelets by propionyl-L-carnitine. Biochem Pharmacol 58:1341-1348, 1999.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Garrelds IM, Elliott GR, Zijlstra FJ, et al: Effects of short- and long-term feeding of L-carnitine and congeners on the production of eicosanoids from rat peritoneal leucocytes. Br J Nutr 72:785-793, 1994.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- OBrien KD, McDonald TO, Chait A, et al: Neovascular expression of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in human atherosclerosis and their relation to intimal leukocyte content. Circulation 93:672-682, 1996.[Abstract/Free Full Text]
- Li H, Cybulsky MI, Gimbrone MA Jr, et al: An atherogenic diet rapidly induces VCAM-1, a cytokine-regulatable mononuclear leukocyte adhesion molecule, in rabbit aortic endothelium. Arterioscler Thromb 13:197-204, 1993.[Abstract/Free Full Text]
- Brevetti G, Perna S, Sabba C, et al: Effect of propionyl-L-carnitine on quality of life in intermittent claudication. Am J Cardiol 79:777-780, 1997.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Brevetti G, di Lisa F, Perna S, et al: Carnitine-related alterations in patients with intermittent claudication: Indication for a focused carnitine therapy. Circulation 93:1685-1689, 1996.[Abstract/Free Full Text]
- Brevetti G, Angelini C, Rosa M, et al: Muscle carnitine deficiency in patients with severe peripheral vascular disease. Circulation 84:1490-1495, 1991.[Abstract/Free Full Text]
- Brevetti G, Fanin M, De Amicis V, et al: Changes in skeletal muscle histology and metabolism in patients undergoing exercise deconditioning: Effect of propionyl-L-carnitine. Muscle Nerve 20:1115-1120, 1997.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Hulsmann WC, Dubelaar ML: Aspects of fatty acid metabolism in vascular endothelial cells. Biochimie 70:681-686, 1988.[Medline]
[Order article via Infotrieve]
- Hulsmann WC, Dubelaar ML: Carnitine requirement of vascular endothelial and smooth muscle cells in imminent ischemia. Mol Cell Biochem 116:125-129, 1992.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Bertelli A, Conte A, Ronca G, et al: Protective effect of propionyl carnitine against peroxidative damage to arterial endothelium membranes. Int J Tissue React 13:41-43, 1991.[Web of Science][Medline]
[Order article via Infotrieve]
- Bertelli A, Conte A, Palmieri L, et al: Effect of propionyl carnitine on energy charge and adenine nucleotide content of cardiac endothelial cells during hypoxia. Int J Tissue React 13:37-40, 1991.[Web of Science][Medline]
[Order article via Infotrieve]
- Sassen LM, Bezstarosti K, Van der Giessen WJ, et al: L-propionylcarnitine increases postischemic blood flow but does not affect recovery of energy charge. Am J Physiol 261(1 Pt 2):H172-H180, 1991.[Medline]
[Order article via Infotrieve]
- Cipolla MJ, Nicoloff A, Rebello T, et al: Propionyl-L-carnitine dilates human subcutaneous arteries through an endothelium-dependent mechanism. J Vasc Surg 29:1097-1103, 1999.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Neunteufl T, Priglinger U, Heher S, et al: Effects of vitamin E on chronic and acute endothelial dysfunction in smokers. J Am Coll Cardiol 35:277-283, 2000.[Abstract/Free Full Text]
- Kanani PM, Sinkey CA, Browning RL, et al: Role of oxidant stress in endothelial dysfunction produced by experimental hyperhomocyst(e)inemia in humans. Circulation 100:1161-1168, 1999.[Abstract/Free Full Text]
- Title LM, Cummings PM, Giddens K, et al: Oral glucose loading acutely attenuates endothelium-dependent vasodilation in healthy adults without diabetes: An effect prevented by vitamins C and E. J Am Coll Cardiol 36:2185-2191, 2000.[Abstract/Free Full Text]
- Spagnoli LG, Orlandi A, Marino B, et al: Propionyl-L-carnitine prevents the progression of atherosclerotic lesions in aged hyperlipemic rabbits. Atherosclerosis 114:29-44, 1995.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Orlandi A, Marcellini M, Pesce D, et al: Propionyl-L-carnitine reduces intimal hyperplasia after injury in normocholesterolemic rabbit carotid artery by modulating proliferation and caspase 3-dependent apoptosis of vascular smooth muscle cells. Atherosclerosis 160:81-89, 2002.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Brevetti G, Silvestro A, Schiano V, et al: Endothelial dysfunction and cardiovascular risk prediction in peripheral arterial disease: Additive value of flow-mediated dilation to ankle-brachial pressure index. Circulation 108:2093-2098, 2003.[Abstract/Free Full Text]
- Gokce N, Keaney JF Jr, Hunter LM, et al: Predictive value of noninvasively determined endothelial dysfunction for long-term cardiovascular events in patients with peripheral vascular disease. J Am Coll Cardiol 41:1769-1775, 2003.[Abstract/Free Full Text]
Angiology, Vol. 57, No. 2,
145-154 (2006)
DOI: 10.1177/000331970605700203

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. Joras and P. Poredos
The association of acute exercise-induced ischaemia with systemic vasodilator function in patients with peripheral arterial disease
Vascular Medicine,
November 1, 2008;
13(4):
255 - 262.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
G. M. Andreozzi, A. Leone, R. Laudani, R. Martin, G. Deinit, and V. Cataldi
Levo-Propionyl-Carnitine Improves the Effectiveness of Supervised Physical Training on the Absolute Claudication Distance in Patients With Intermittent Claudication
Angiology,
March 1, 2008;
59(1):
84 - 89.
[Abstract]
[PDF]
|
 |
|
|
|